A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...
A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...
An international research team led by the Medical University of Vienna has demonstrated for the first time that thyroid hormone plays a key role in the development and progression of prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback